HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sébastien Küry Selected Research

Acrodermatitis enteropathica

10/2017Characterization of zinc amino acid complexes for zinc delivery in vitro using Caco-2 cells and enterocytes from hiPSC.
5/2015Acrodermatitis Enteropathica: A Novel SLC39A4 Gene Mutation in a Patient with Normal Zinc Levels.
12/2011Acrodermatitis enteropathica: an uncommon differential diagnosis in childhood - first description of a new sequence variant.
9/2010Acrodermatitis enteropathica: a review of 29 Tunisian cases.
6/2009An update on mutations of the SLC39A4 gene in acrodermatitis enteropathica.
10/2003Mutation spectrum of human SLC39A4 in a panel of patients with acrodermatitis enteropathica.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sébastien Küry Research Topics

Disease

10Intellectual Disability (Idiocy)
01/2021 - 12/2015
8Neurodevelopmental Disorders
01/2022 - 01/2016
7Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 07/2007
6Neoplasms (Cancer)
04/2019 - 10/2012
6Acrodermatitis enteropathica
10/2017 - 10/2003
4Autistic Disorder (Autism)
01/2021 - 01/2019
3Colonic Neoplasms (Colon Cancer)
11/2015 - 10/2012
2Lung Neoplasms (Lung Cancer)
12/2018 - 12/2016
2Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)
01/2014 - 10/2012
1Alzheimer Disease (Alzheimer's Disease)
01/2021
1Autism Spectrum Disorder
01/2021
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2021
1Liver Failure
11/2020
1Epilepsy (Aura)
01/2020
1Premature Aging
01/2020
1Leukoencephalopathies
01/2020
1Dysostoses
01/2020
1Alopecia (Baldness)
01/2019
1Cataract (Cataracts)
01/2019
1chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature
01/2018
1Primary Immunodeficiency Diseases
01/2018
1Deafness (Deaf Mutism)
02/2017
1Growth Disorders
01/2017
1Seizures (Absence Seizure)
01/2016
1Atrophy
12/2015
1Hepatolenticular Degeneration (Wilson's Disease)
04/2015
1Genetic Risk Score
11/2013
1Sigmoid Neoplasms
10/2012
1Ichthyosis (Xeroderma)
01/2012
1Diarrhea
12/2011
1Impetigo (Impetigo Contagiosa)
12/2011
1Superinfection
12/2011
1Tuberous Sclerosis (Bourneville's Disease)
09/2009
1Hamartoma
09/2009
1Inflammation (Inflammations)
11/2008
1Carcinogenesis
11/2008

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2012
6ZincIBA
05/2015 - 10/2003
4Proteasome Endopeptidase Complex (Proteasome)IBA
01/2021 - 01/2017
4Biological ProductsIBA
04/2019 - 07/2015
3zinc-binding protein (zinc binding protein)IBA
12/2015 - 10/2003
2Transcription Factors (Transcription Factor)IBA
01/2021 - 04/2013
2A-Form DNA (A-DNA)IBA
01/2014 - 04/2013
1Pharmaceutical PreparationsIBA
01/2021
1UbiquitinIBA
01/2021
1Sin3 Histone Deacetylase and Corepressor ComplexIBA
01/2021
1Co-Repressor ProteinsIBA
01/2021
1Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA
11/2020
1Transaminases (Aminotransferases)IBA
11/2020
1VimentinIBA
01/2020
1EnzymesIBA
01/2020
1Eukaryotic Initiation Factor-2B (Eukaryotic Initiation Factor 2B)IBA
01/2020
1RNA Helicases (RNA Helicase)IBA
01/2020
1CholesterolIBA
01/2019
1Histone Acetyltransferases (Histone Acetyltransferase)IBA
01/2019
1lanosterol synthaseIBA
01/2019
1Protein Isoforms (Isoforms)IBA
12/2018
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
12/2018
1N-acetyltryptophanamide (NATA)IBA
01/2018
1Protein Kinases (Protein Kinase)IBA
11/2017
1Deubiquitinating EnzymesIBA
04/2017
1Adenosine Triphosphatases (ATPase)IBA
02/2017
1ATP dependent 26S protease (26S proteasome)IBA
02/2017
1Proteoglycans (Proteoglycan)IBA
01/2017
1GlycosaminoglycansIBA
01/2017
1telomerase RNA (bTR)IBA
12/2016
1P-2 (P 2)IBA
10/2016
1PhosphoproteinsIBA
04/2016
1GTP-Binding Proteins (G-Protein)IBA
01/2016
1Guanine NucleotidesIBA
01/2016
1ManganeseIBA
12/2015
1Adenosine Triphosphate (ATP)IBA
04/2015
1Peptides (Polypeptides)IBA
04/2015
1CopperIBA
04/2015
1Calcibiotic Root Canal SealerIBA
01/2014
1Vitamin DFDA LinkGeneric
11/2013
1Antineoplastic Agents (Antineoplastics)IBA
11/2013
1hydroxide ionIBA
11/2013
1Genetic Markers (Genetic Marker)IBA
11/2013
125-hydroxyvitamin DIBA
11/2013
1Vitamin D3 24-HydroxylaseIBA
11/2013
1Nucleic AcidsIBA
04/2013
1Carrier Proteins (Binding Protein)IBA
04/2013
1Laminin (Merosin)IBA
04/2013
1Cyclin D2IBA
04/2013
1laminin gamma 1IBA
04/2013
1CateninsIBA
04/2013
1MutL Protein Homolog 1IBA
10/2012
1Histidine (L-Histidine)FDA Link
12/2011
1Anti-Bacterial Agents (Antibiotics)IBA
12/2011
1Local Anti-Infective Agents (Antiseptics)IBA
12/2011
1trans-sodium crocetinate (crocetin)IBA
09/2009
1Insulin (Novolin)FDA Link
11/2008
1CarbonIBA
11/2008
1XenobioticsIBA
11/2008
1Interleukin-8 (Interleukin 8)IBA
11/2008
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
07/2007

Therapy/Procedure

1Chemoprevention
01/2021
1Therapeutics
12/2011